WEX is trading higher as investors re-price the company amid an escalating activist campaign headed into the May 5, 2026 annual meeting. The latest flashpoint is Impactive Capital’s push for board seats and its effort to block CEO Melissa Smith’s re-election to the board, a stance that elevates the odds of leadership and strategy changes becoming part of the near-term narrative.

Impactive is pressing shareholders to vote for board change, keeping attention on whether WEX could face sharper governance oversight and increased pressure on capital allocation and operational execution. WEX has countered by soliciting votes for its full slate and highlighting what it describes as potential regulatory approval issues tied to the activist’s campaign—adding a risk-and-uncertainty layer that can also increase volatility around headlines and filings.

Key dates and documents are now the roadmap: the May 5, 2026 annual meeting and any proxy-adviser recommendations that could influence institutional votes. Investors are also monitoring whether any regulatory process becomes a gating item for the activist’s efforts, and whether either side signals a settlement (board seats, governance changes) that could reduce uncertainty but also reset expectations for follow-on actions.